278 Preclinical development of LYL119, a ROR1-targeted CAR T-cell product incorporating four novel T-cell reprogramming technologies to overcome barriers to effective cell therapy for solid tumors

Autor:	Rachel C Lynn, Purnima Sundar, Omar Ali, Christina Cheung, Shobha Potluri, Meritxell Galindo Casas, Candace Sims, Viola C Lam, Aileen Li, Jessica Barragan, Jessica Briones, Esha Afreen, Grant Vavra, Jia Lu, Rowena Martinez, Christina Ta, Eskedar Nigatu, Alexander S Cheung
Jazyk:	angličtina
Rok vydání:	2023
Předmět:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Zdroj:	Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Druh dokumentu:	article
ISSN:	2051-1426
DOI:	10.1136/jitc-2023-SITC2023.0278
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/8290649cd6d6401689d7af95ad7d49d4 Zobrazit plný text záznamu View record in DOAJ